Nanopep
Fangshan
About Nanopep
Nanopep is a nano-biomedical high-tech company. They develop platform technology to enable personalized medicine, such as SPRI and MALDI-TOF MS microarrays for massively parallel peptide screening, and an efficient platform for the enrichment of circulating tumor cells using nano-beads. The company claims that the latter technology will power its protein-based liquid biopsy assay.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $7.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2017)
- Website: nanopep.com
- Phone: +86 400-890-2014
Industries & Categories
Biotechnology, Health Care, Medical, Precision Medicine
Canonical: https://fsome.com/organization/nanopep-181613 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.